凝血因子表达和动脉血栓的组成在癌症相关的中风中
Joonsang Yoo1, Il Kwon2, Sungeun Kim2
1Department of Neurology, Yongin Severance Hospital (J.Y.), Yonsei University College of Medicine, Korea.
Stroke
|October 27, 2023
概括
经历中风的癌症患者有血栓,血小板和血栓的数量显著增加. 这一发现突出了动脉血栓形成的关键作用,并提出了治疗策略,以预防癌症患者中风.
科学领域:
- 神经学 神经学
- 在瘤学瘤学.
- 血液学 血液学 血液学
背景情况:
- 由于瘤细胞激活血小板和凝血级联,癌症显著增加了中风风险.
- 了解癌症相关中风中的血栓组成对于确定有效的治疗策略至关重要.
- 血栓分析可以揭示血栓形成的潜在机制,指导治疗干预.
研究的目的:
- 研究癌症相关中风患者脑血栓内凝血因子的组成和表达.
- 为了比较癌症患者和没有癌症的匹配对照组之间的血栓组成.
- 在癌症的背景下,确定导致动脉血栓形成的特定因素.
主要方法:
- 一组为中风进行血管内血栓切除术的患者被分为癌症相关的中风和对照组.
- 基于年龄和性别的倾向性得分匹配用于组比较.
- 免疫组织化学被用来分析血栓组成和凝血因子表达.
主要成果:
- 与对照人群相比,与癌症相关的中风血栓显示出血小板 (51.3%与9.5%) 和血栓 (26.2%与4.5%) 的比例明显更高.
- 在癌症组中观察到高水平的组织因子 (0.60%对0.37%).
- 癌症组的X因子水平较低 (1.25%对2.33%),癌症患者中血栓和血小板之间存在正相关性.
结论:
- 与癌症相关的中风中脑瘤的特征是血小板,血和组织因子的增加.
- 这些成分在癌症患者观察到的动脉血栓形成中起着关键作用.
- 这些发现为预防癌症患者中风提供了治疗前景.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
723
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
723
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.0K
01:09Coagulation
6.9K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.9K
01:16Clot Retraction and Fibrinolysis
6.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.3K
01:30Venous Thrombosis I: Introduction
11
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
11
01:24Disorders of Hemostasis
963
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
963